February 6, 2020 at 4:05 PM EST PDF Version BURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Q4 2019 Results Record sales of $30.2mm, +6% (flat organic) vs. Q4 2018 Operating income […]
Author: Ken Dropiewski
CorMatrix® Cardiovascular, Inc. receives FDA approval to expand and enroll 20 additional patients in the adult arm of its early feasibility IDE study of the Cor® TRICUSPID ECM® valve for pediatric and adult patients
ATLANTA, Feb. 7, 2020 /PRNewswire/ — CorMatrix®Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced receiving FDA approval to expand and enroll 20 additional patients in the adult arm, including up to 4 additional cardiac surgery research and investigative centers, for its early feasibility IDE study of the Cor® TRICUSPID ECM® valve* for […]
Amarin Honored by BioNJ with Innovator Award for VASCEPA® Development and Regulatory Approval
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), announced today that BioNJ awarded Amarin with an Innovator Award in recognition of the approval of a new indication for VASCEPA® (icosapent ethyl) by the U.S. Food and Drug Administration (FDA) in December 2019. This […]
SANUWAVE Health Appoints Dr. Tom Price to Its Board of Directors
SUWANEE, GA, Feb. 07, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s extensive experience in public service, serving the state of […]
Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension
SAINT PAUL, Minn.–(BUSINESS WIRE)–Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria CV Pulmonary Hypertension System (Aria CV PH System). The Breakthrough Devices Program (BDP) is intended to […]
BD Announces Results For 2020 First Fiscal Quarter; Lowers Fiscal 2020 Guidance
– As reported, revenues of $4.225 billion increased 1.6 percent. – On a currency-neutral basis, revenues increased 2.5 percent. – As reported, diluted earnings per share of $0.87 decreased 57.6 percent. – As adjusted, diluted earnings per share of $2.65 decreased 1.9 percent, or 0.4 percent on a currency-neutral basis. […]
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
JanOne’s lead drug clinical candidate TV1001SR to treat PAD and associated pain will be manufactured by CoreRX Pharma with phase 2b trials expected to begin Q4 2020 LAS VEGAS, Feb. 6, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs […]
XableCath™ Receives CE Mark
New peripheral venous and arterial crossing tool paves a path to Europe SALT LAKE CITY, Feb. 06, 2020 (GLOBE NEWSWIRE) — XableCath, Inc., announced its XableCath™ Crossing Catheters have received CE Mark for peripheral use. Its crossing devices will be available for sale in Europe in two versions, a blunt […]
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call Information
WAYNE, Pa., Feb. 06, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February […]
Cardiovascular Systems, Inc. Reports Fiscal 2020 Second-Quarter Financial Results
Conference Call Scheduled for Today, February 5, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $68.3 million increased 13.5% from second quarter last year Net loss was $3.4 million, or $0.10 per basic and diluted share Company raises low end of fiscal 2020 revenue guidance range ST. PAUL, […]
Recent
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Popular
- No commented posts yet